DE60137340D1 - Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen - Google Patents

Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen

Info

Publication number
DE60137340D1
DE60137340D1 DE60137340T DE60137340T DE60137340D1 DE 60137340 D1 DE60137340 D1 DE 60137340D1 DE 60137340 T DE60137340 T DE 60137340T DE 60137340 T DE60137340 T DE 60137340T DE 60137340 D1 DE60137340 D1 DE 60137340D1
Authority
DE
Germany
Prior art keywords
hiv
treatment
inhibitors
infections caused
replication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60137340T
Other languages
English (en)
Inventor
Christian Devaux
Veronique Hebmann
Gilles Divita
Frederic Heitz
Catherine May Morris
Jean Mery
Roger S Goody
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE60137340D1 publication Critical patent/DE60137340D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60137340T 2000-08-25 2001-08-21 Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen Expired - Lifetime DE60137340D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/648,557 US7790171B1 (en) 2000-08-25 2000-08-25 Antiviral peptides obtained from the tryptophan-rich hydrophobic cluster of the HIV-1 reverse transcriptase
PCT/IB2001/001825 WO2002015661A2 (en) 2000-08-25 2001-08-21 Inhibitors of hiv replication and method of treatment of hiv infections

Publications (1)

Publication Number Publication Date
DE60137340D1 true DE60137340D1 (de) 2009-02-26

Family

ID=24601279

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60137340T Expired - Lifetime DE60137340D1 (de) 2000-08-25 2001-08-21 Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen

Country Status (6)

Country Link
US (2) US7790171B1 (de)
EP (1) EP1311538B1 (de)
AT (1) ATE420103T1 (de)
AU (1) AU2001292153A1 (de)
DE (1) DE60137340D1 (de)
WO (1) WO2002015661A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2417454A1 (en) * 2000-07-31 2002-02-07 Active Motif Peptide-mediated delivery of molecules into cells
AU2003233310A1 (en) * 2002-05-08 2003-11-11 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Agent and method for transporting biologically active molecules in cells
EP2174948A1 (de) * 2008-09-26 2010-04-14 Centre National De La Recherche Scientifique Antivirale Polypeptide
JP2012146377A (ja) * 2011-01-14 2012-08-02 Elpida Memory Inc 半導体装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
JP4873810B2 (ja) 1999-10-05 2012-02-08 エピミューン インコーポレイテッド ペプチドおよび核酸組成物を使用する、ヒト免疫不全ウイルス−１に対する細胞性免疫応答の誘導
CA2417454A1 (en) 2000-07-31 2002-02-07 Active Motif Peptide-mediated delivery of molecules into cells

Also Published As

Publication number Publication date
WO2002015661A3 (en) 2003-01-23
AU2001292153A1 (en) 2002-03-04
US20110064793A1 (en) 2011-03-17
WO2002015661A2 (en) 2002-02-28
EP1311538A2 (de) 2003-05-21
ATE420103T1 (de) 2009-01-15
US7790171B1 (en) 2010-09-07
EP1311538B1 (de) 2009-01-07
WO2002015661A8 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
HUP0301842A2 (hu) Laktám vegyület, a vegyületet tartalmazó gyógyszerkészítmény és alkalmazása gyógyszerkészítmény elżállítására
HUP0000492A1 (hu) N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával
CO4970837A1 (es) Inhibidores de captesina de nitrilo de dipeptido .
SE0002202D0 (sv) New peptides
RS52537B (en) ACTIVIN-ACTRII ANTAGONISTS AND USES FOR ANEMIA TREATMENT
HUP0202512A2 (hu) Fehérjék polimerizációját gátló anyagok és eljárások ezek alkalmazására
NO974147D0 (no) Heterocykelkarbonyl aminosyre hydroksyetylamino sulfonamid retroviral protease
CY1109631T1 (el) Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
WO2005002500A3 (en) Inhibitors of coronavirus
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
ATE389013T1 (de) Faktor x-analoge mit verbesserter fähigkeit zur aktivierung
DE60137340D1 (de) Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen
HUP0202729A2 (hu) Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69330268D1 (de) Hämoregulierende peptide
HUP0301523A2 (hu) VEGF-peptidek és alkalmazásuk angiogenezis gátlására
UY26911A1 (es) Ácidos amino (oxo) acéticos inhibidores de la proteina tirosina fosfatasa
HUP0303181A2 (hu) 4-Foszfodiészteráz típusú inhibitorok alkalmazása miokardiális betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
ATE285244T1 (de) Tripeptide und deren derivate zur behandlung von postläsionalen krankheiten des nervensystems
ATE46173T1 (de) Pharmakologisch aktive peptide.
ATE297720T1 (de) Campher wässrige lösung zur behandlung degenerativer und autoimmuner erkrankungen sowie als immunomodulator
DE60207550D1 (de) Tripeptidderivate zur behandlung von postläsionalen krankheiten des nervensystems
ATE360432T1 (de) Peptid zur behandlung von nervenerkrankungen
WO2003089472A3 (en) Anti-nls scfv and peptides and uses thereof in nuclear import inhibition
ATE386524T1 (de) Wässrige lösungen von moxaverin zur behandlung der erektilen dysfunktion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition